LATYVAR
Live / Applied — Fourth extension granted (statement of use) (as of 18 Sept 2025)
What this means for you
Not registered yet, but its 09 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97747016
- Mark type
- Stylized text
- Filed
- 09 Jan 2023
- Published for opposition
- 22 Aug 2023
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for humans, namely, treatment for gynecological related diseases, disorders and deficiencies; pharmaceutical preparations for humans, namely, treatment for cardiological related diseases, disorders and deficiencies; pharmaceutical preparations for humans, namely, treatment for oncological related diseases, disorders and deficiencies
Owner
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
Prosecution history
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — SOU EXTENSION 4 GRANTED
- 18 Sept 2025 — SOU EXTENSION 4 FILED
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2025 — SOU EXTENSION 3 GRANTED
- 10 Mar 2025 — SOU EXTENSION 3 FILED
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2024 — SOU EXTENSION 2 GRANTED
- 20 Sept 2024 — SOU EXTENSION 2 FILED